Giving The Gov't Drug Patent March-In Authority Is Bad Policy

By Wayne Winegarden · December 13, 2023, 5:15 PM EST

In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to "be a factor in considering whether a drug...

To view the full article, register now.